Elevated Levels of T Helper 17 Cells Are Associated with Disease Activity in Patients with Rheumatoid Arthritis
Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokin...
Saved in:
Published in | Annals of laboratory medicine Vol. 33; no. 1; pp. 52 - 59 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society for Laboratory Medicine
01.01.2013
대한진단검사의학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2234-3806 2234-3814 2234-3814 |
DOI | 10.3343/alm.2013.33.1.52 |
Cover
Abstract | Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokine levels in the peripheral blood of RA patients.
Peripheral blood mononuclear cells from 55 RA and 20 osteoarthritis (OA) patients were stimulated with mitogen, and the distributions of CD4(+)Interferon (INF)(+)IL-17(-) (Th1 cells) and CD4(+)INF-IL-17(+) (Th17 cells) were examined by flow cytometry. Serum levels of IL-6, IL-17, IL-21, IL-23, and tumor necrosis factor (TNF)-α were measured by ELISA. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were recorded. The 28-joint disease activity score (DAS28) was also assessed.
The median percentage of Th17 cells was higher in RA patients than in OA patients (P=0.04), and in active than in inactive RA (P=0.03), whereas that of Th1 cells was similar in both groups. Similarly, the levels of IL-17, IL-21, and IL-23 were detected in a significantly higher proportion of RA patients than OA patients and the frequencies of detectable IL-6, IL-17, and IL-21 were higher in active RA than in inactive RA group. The percentage of Th17 cells positively correlated with the DAS28, ESR, and CRP levels.
These observations suggest that Th17 cells and Th17-related cytokines play an important role in RA pathogenesis and that the level of Th17 cells in peripheral blood is associated with disease activity in RA. |
---|---|
AbstractList | Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokine levels in the peripheral blood of RA patients.BACKGROUNDInterleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokine levels in the peripheral blood of RA patients.Peripheral blood mononuclear cells from 55 RA and 20 osteoarthritis (OA) patients were stimulated with mitogen, and the distributions of CD4(+)Interferon (INF)(+)IL-17(-) (Th1 cells) and CD4(+)INF-IL-17(+) (Th17 cells) were examined by flow cytometry. Serum levels of IL-6, IL-17, IL-21, IL-23, and tumor necrosis factor (TNF)-α were measured by ELISA. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were recorded. The 28-joint disease activity score (DAS28) was also assessed.METHODSPeripheral blood mononuclear cells from 55 RA and 20 osteoarthritis (OA) patients were stimulated with mitogen, and the distributions of CD4(+)Interferon (INF)(+)IL-17(-) (Th1 cells) and CD4(+)INF-IL-17(+) (Th17 cells) were examined by flow cytometry. Serum levels of IL-6, IL-17, IL-21, IL-23, and tumor necrosis factor (TNF)-α were measured by ELISA. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were recorded. The 28-joint disease activity score (DAS28) was also assessed.The median percentage of Th17 cells was higher in RA patients than in OA patients (P=0.04), and in active than in inactive RA (P=0.03), whereas that of Th1 cells was similar in both groups. Similarly, the levels of IL-17, IL-21, and IL-23 were detected in a significantly higher proportion of RA patients than OA patients and the frequencies of detectable IL-6, IL-17, and IL-21 were higher in active RA than in inactive RA group. The percentage of Th17 cells positively correlated with the DAS28, ESR, and CRP levels.RESULTSThe median percentage of Th17 cells was higher in RA patients than in OA patients (P=0.04), and in active than in inactive RA (P=0.03), whereas that of Th1 cells was similar in both groups. Similarly, the levels of IL-17, IL-21, and IL-23 were detected in a significantly higher proportion of RA patients than OA patients and the frequencies of detectable IL-6, IL-17, and IL-21 were higher in active RA than in inactive RA group. The percentage of Th17 cells positively correlated with the DAS28, ESR, and CRP levels.These observations suggest that Th17 cells and Th17-related cytokines play an important role in RA pathogenesis and that the level of Th17 cells in peripheral blood is associated with disease activity in RA.CONCLUSIONSThese observations suggest that Th17 cells and Th17-related cytokines play an important role in RA pathogenesis and that the level of Th17 cells in peripheral blood is associated with disease activity in RA. Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokine levels in the peripheral blood of RA patients. Peripheral blood mononuclear cells from 55 RA and 20 osteoarthritis (OA) patients were stimulated with mitogen, and the distributions of CD4(+)Interferon (INF)(+)IL-17(-) (Th1 cells) and CD4(+)INF-IL-17(+) (Th17 cells) were examined by flow cytometry. Serum levels of IL-6, IL-17, IL-21, IL-23, and tumor necrosis factor (TNF)-α were measured by ELISA. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were recorded. The 28-joint disease activity score (DAS28) was also assessed. The median percentage of Th17 cells was higher in RA patients than in OA patients (P=0.04), and in active than in inactive RA (P=0.03), whereas that of Th1 cells was similar in both groups. Similarly, the levels of IL-17, IL-21, and IL-23 were detected in a significantly higher proportion of RA patients than OA patients and the frequencies of detectable IL-6, IL-17, and IL-21 were higher in active RA than in inactive RA group. The percentage of Th17 cells positively correlated with the DAS28, ESR, and CRP levels. These observations suggest that Th17 cells and Th17-related cytokines play an important role in RA pathogenesis and that the level of Th17 cells in peripheral blood is associated with disease activity in RA. Background: Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokine levels in the peripheral blood of RA patients. Methods: Peripheral blood mononuclear cells from 55 RA and 20 osteoarthritis (OA) patients were stimulated with mitogen, and the distributions of CD4+Interferon (INF)+IL-17-(Th1 cells) and CD4+INF-IL-17+ (Th17 cells) were examined by flow cytometry. Serum levels of IL-6, IL-17, IL-21, IL-23, and tumor necrosis factor (TNF)-α were measured by ELISA. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were recorded. The 28-joint disease activity score (DAS28) was also assessed. Results: The median percentage of Th17 cells was higher in RA patients than in OA patients (P =0.04), and in active than in inactive RA (P =0.03), whereas that of Th1 cells was similar in both groups. Similarly, the levels of IL-17, IL-21, and IL-23 were detected in a significantly higher proportion of RA patients than OA patients and the frequencies of detectable IL-6, IL-17, and IL-21 were higher in active RA than in inactive RA group. The percentage of Th17 cells positively correlated with the DAS28, ESR, and CRP levels. Conclusions: These observations suggest that Th17 cells and Th17-related cytokines play an important role in RA pathogenesis and that the level of Th17 cells in peripheral blood is associated with disease activity in RA. KCI Citation Count: 33 |
Author | Kang, Seongwook Kim, Jimyung Kim, Jinhyun Kwon, Gyechul Koo, Sunhoe |
AuthorAffiliation | 1 Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea 2 Department of Rheumatology, Chungnam National University College of Medicine, Daejeon, Korea |
AuthorAffiliation_xml | – name: 1 Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea – name: 2 Department of Rheumatology, Chungnam National University College of Medicine, Daejeon, Korea |
Author_xml | – sequence: 1 givenname: Jimyung surname: Kim fullname: Kim, Jimyung organization: Departments of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea – sequence: 2 givenname: Seongwook surname: Kang fullname: Kang, Seongwook organization: Departments of Rheumatology, Chungnam National University College of Medicine, Daejeon, Korea – sequence: 3 givenname: Jinhyun surname: Kim fullname: Kim, Jinhyun organization: Departments of Rheumatology, Chungnam National University College of Medicine, Daejeon, Korea – sequence: 4 givenname: Gyechul surname: Kwon fullname: Kwon, Gyechul organization: Departments of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea – sequence: 5 givenname: Sunhoe surname: Koo fullname: Koo, Sunhoe organization: Departments of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23301223$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001730163$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1UUtvEzEQtlARLaF3TshHLgl-7-4FKUoLrRQJVIWzNfHOEtPddbCdoP57nKStAAlfxjP-HvJ8r8nZGEYk5C1nMymV_AD9MBOMy9LN-EyLF-RCCKmmsubq7PnOzDm5TOkHK8cwLhr2ipwLKctVyAsSrnvcQ8aWLnGPfaKhoyt6g_0WI-UVXWBfhvOIdJ5ScP4I_eXzhl75hJDK3GW_9_mB-pF-hexxzOmEuNvgboAcfFsE8ib67NMb8rKDPuHlY52Qb5-uV4ub6fLL59vFfDl1SvM8rUEBYtNUErRpG1E1HVRtjW29VsCVBikB1nVViWaNXVszBka1qBrtjAFj5IS8P-mOsbP3ztsA_li_B3sf7fxudWu5ErI4TMjHE3S7Ww_YuvKBCL3dRj9AfDgS_34Z_abI7K3UUvOjwKPXNoafO0zZDj65sjgYMeyS5aIqgRkldIG--9Pr2eQpkAIwJ4CLIaWInXU-l62Gg7XvLWf2EL4t4dtD-KWz3GpRiOwf4pP2fym_ASaWsmU |
CitedBy_id | crossref_primary_10_1007_s00005_015_0344_z crossref_primary_10_1016_j_ejr_2020_02_009 crossref_primary_10_1016_j_bcp_2020_113822 crossref_primary_10_1111_cei_12860 crossref_primary_10_2119_molmed_2015_00057 crossref_primary_10_1016_j_ejr_2014_06_004 crossref_primary_10_1302_2046_3758_117_BJR_2021_0594_R1 crossref_primary_10_1111_apm_12399 crossref_primary_10_1007_s10067_013_2476_z crossref_primary_10_1016_j_intimp_2022_109271 crossref_primary_10_1093_rheumatology_kez587 crossref_primary_10_1080_14789450_2021_1908892 crossref_primary_10_1186_s13075_017_1349_2 crossref_primary_10_1016_j_yexmp_2021_104689 crossref_primary_10_3389_fimmu_2019_00798 crossref_primary_10_1089_bio_2022_0003 crossref_primary_10_1002_term_2958 crossref_primary_10_1016_j_vaccine_2018_04_062 crossref_primary_10_1155_2016_3507503 crossref_primary_10_1016_j_intimp_2015_12_011 crossref_primary_10_1038_nrrheum_2015_53 crossref_primary_10_1371_journal_pone_0164757 crossref_primary_10_1111_sji_13226 crossref_primary_10_1155_2015_487230 crossref_primary_10_4103_1110_161X_168164 crossref_primary_10_1371_journal_pone_0242092 crossref_primary_10_3390_ph17040465 crossref_primary_10_1016_j_lfs_2013_07_022 crossref_primary_10_1111_apm_12629 crossref_primary_10_3390_pharmaceutics14020404 crossref_primary_10_1007_s00296_013_2788_y crossref_primary_10_1111_odi_14952 crossref_primary_10_1007_s11684_015_0388_9 crossref_primary_10_1038_s41392_023_01471_y crossref_primary_10_1016_j_jaut_2016_02_008 crossref_primary_10_1002_clc_24065 crossref_primary_10_1007_s00018_021_04076_2 crossref_primary_10_1155_2015_751793 crossref_primary_10_3109_09273948_2015_1063672 crossref_primary_10_1189_jlb_3A0714_327R crossref_primary_10_1080_08916934_2019_1631812 crossref_primary_10_1007_s00109_014_1232_4 crossref_primary_10_2217_epi_13_87 crossref_primary_10_1002_JLB_4RU0619_197R crossref_primary_10_1111_sji_12197 crossref_primary_10_1186_s12929_022_00790_6 crossref_primary_10_1155_2013_203705 crossref_primary_10_1016_j_patbio_2015_04_004 crossref_primary_10_1016_j_mito_2023_10_004 crossref_primary_10_1007_s10067_019_04768_y crossref_primary_10_1177_0022034521990652 crossref_primary_10_1155_2015_519638 |
Cites_doi | 10.1186/ar3431 10.1002/art.21749 10.1080/03009740701286813 10.1038/ni0407-345 10.1016/S0140-6736(09)60008-8 10.1007/s10875-011-9540-8 10.1016/j.clim.2010.10.002 10.1186/ar2477 10.4049/jimmunol.179.3.1449 10.3899/jrheum.110697 10.1007/s12026-007-8014-9 10.1002/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E 10.1172/JCI5703 10.1111/j.1365-3083.2009.02361.x 10.1136/ard.2007.080341 10.1002/art.24568 10.1038/nri2094 10.1002/art.27622 10.1002/art.1780380107 10.1002/art.27186 10.1016/0009-9120(93)90032-2 10.1084/jem.183.6.2593 10.3343/kjlm.2010.30.3.301 10.3899/jrheum.100259 10.1038/ni1488 10.4049/jimmunol.160.7.3513 |
ContentType | Journal Article |
Copyright | The Korean Society for Laboratory Medicine. 2013 |
Copyright_xml | – notice: The Korean Society for Laboratory Medicine. 2013 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
DOI | 10.3343/alm.2013.33.1.52 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2234-3814 |
EndPage | 59 |
ExternalDocumentID | oai_kci_go_kr_ARTI_142397 PMC3535197 23301223 10_3343_alm_2013_33_1_52 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 5-W 53G 8JR 8XY 9ZL AAYXX ACYCR ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION C~G DIK DYU EF. GX1 HYE KQ8 M48 PGMZT RPM CGR CUY CVF ECGQY ECM EIF EMOBN M~E NPM OK1 7X8 5PM |
ID | FETCH-LOGICAL-c451t-8a4aee9973a56d9279fa7d8ed8b4a145a33aab87729befd800a64de495c66a663 |
IEDL.DBID | M48 |
ISSN | 2234-3806 2234-3814 |
IngestDate | Sun Mar 09 07:53:59 EDT 2025 Thu Aug 21 14:30:52 EDT 2025 Thu Jul 10 18:19:27 EDT 2025 Thu Jan 02 22:14:06 EST 2025 Thu Apr 24 23:06:35 EDT 2025 Tue Jul 01 03:11:31 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Cytokines T helper 17 cell Rheumatoid arthritis T helper 1 cell |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c451t-8a4aee9973a56d9279fa7d8ed8b4a145a33aab87729befd800a64de495c66a663 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000327.2013.33.1.008 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3343/alm.2013.33.1.52 |
PMID | 23301223 |
PQID | 1273346425 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_142397 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3535197 proquest_miscellaneous_1273346425 pubmed_primary_23301223 crossref_citationtrail_10_3343_alm_2013_33_1_52 crossref_primary_10_3343_alm_2013_33_1_52 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-01-01 |
PublicationDateYYYYMMDD | 2013-01-01 |
PublicationDate_xml | – month: 01 year: 2013 text: 2013-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Annals of laboratory medicine |
PublicationTitleAlternate | Ann Lab Med |
PublicationYear | 2013 |
Publisher | The Korean Society for Laboratory Medicine 대한진단검사의학회 |
Publisher_xml | – name: The Korean Society for Laboratory Medicine – name: 대한진단검사의학회 |
References | Zivojinovic (10.3343/alm.2013.33.1.52_ref21) 2012; 39 Yamada (10.3343/alm.2013.33.1.52_ref10) 2008; 67 Zhang (10.3343/alm.2013.33.1.52_ref9) 2011; 31 McInnes (10.3343/alm.2013.33.1.52_ref2) 2007; 7 Shahrara (10.3343/alm.2013.33.1.52_ref18) 2008; 10 Rasmussen (10.3343/alm.2013.33.1.52_ref12) 2010; 37 Kang (10.3343/alm.2013.33.1.52_ref20) 2010; 30 Zhou (10.3343/alm.2013.33.1.52_ref13) 2007; 8 Iwamoto (10.3343/alm.2013.33.1.52_ref14) 2007; 179 Moore (10.3343/alm.2013.33.1.52_ref25) 1993; 26 Leipe (10.3343/alm.2013.33.1.52_ref23) 2010; 62 Bettelli (10.3343/alm.2013.33.1.52_ref8) 2007; 8 Kim (10.3343/alm.2013.33.1.52_ref16) 2007; 36 Fossiez (10.3343/alm.2013.33.1.52_ref5) 1996; 183 Kokkonen (10.3343/alm.2013.33.1.52_ref24) 2010; 62 Paradowska-Gorycka (10.3343/alm.2013.33.1.52_ref26) 2010; 71 Kirkham (10.3343/alm.2013.33.1.52_ref4) 2006; 54 Guedez (10.3343/alm.2013.33.1.52_ref3) 2001; 44 Kotake (10.3343/alm.2013.33.1.52_ref7) 1999; 103 Prevoo (10.3343/alm.2013.33.1.52_ref17) 1995; 38 Chen (10.3343/alm.2013.33.1.52_ref22) 2008; 41 Shen (10.3343/alm.2013.33.1.52_ref19) 2009; 60 Jovanovic (10.3343/alm.2013.33.1.52_ref6) 1998; 160 Klareskog (10.3343/alm.2013.33.1.52_ref1) 2009; 373 Zizzo (10.3343/alm.2013.33.1.52_ref11) 2011; 138 Chen (10.3343/alm.2013.33.1.52_ref15) 2011; 13 18710567 - Arthritis Res Ther. 2008;10(4):R93 7818570 - Arthritis Rheum. 1995 Jan;38(1):44-8 11665984 - Arthritis Rheum. 2001 Oct;44(10):2413-24 20112361 - Arthritis Rheum. 2010 Feb;62(2):383-91 17581537 - Nat Immunol. 2007 Sep;8(9):967-74 16572447 - Arthritis Rheum. 2006 Apr;54(4):1122-31 20415779 - Scand J Immunol. 2010 Mar;71(3):134-45 19157532 - Lancet. 2009 Feb 21;373(9664):659-72 21801431 - Arthritis Res Ther. 2011;13(4):R126 20682664 - J Rheumatol. 2010 Oct;37(10):2014-20 17641010 - J Immunol. 2007 Aug 1;179(3):1449-57 19479869 - Arthritis Rheum. 2009 Jun;60(6):1647-56 18063670 - Ann Rheum Dis. 2008 Sep;67(9):1299-304 20603592 - Korean J Lab Med. 2010 Jun;30(3):301-6 20583102 - Arthritis Rheum. 2010 Oct;62(10):2876-85 8676080 - J Exp Med. 1996 Jun 1;183(6):2593-603 17763202 - Scand J Rheumatol. 2007 Jul-Aug;36(4):259-64 8485860 - Clin Biochem. 1993 Apr;26(2):75-84 17525752 - Nat Rev Immunol. 2007 Jun;7(6):429-42 9531313 - J Immunol. 1998 Apr 1;160(7):3513-21 21556937 - J Clin Immunol. 2011 Aug;31(4):606-14 22133625 - J Rheumatol. 2012 Jan;39(1):18-21 17375096 - Nat Immunol. 2007 Apr;8(4):345-50 18172584 - Immunol Res. 2008;41(2):87-102 10225978 - J Clin Invest. 1999 May;103(9):1345-52 21056009 - Clin Immunol. 2011 Jan;138(1):107-16 |
References_xml | – volume: 13 start-page: R126 year: 2011 ident: 10.3343/alm.2013.33.1.52_ref15 publication-title: Arthritis Res Ther doi: 10.1186/ar3431 – volume: 54 start-page: 1122 year: 2006 ident: 10.3343/alm.2013.33.1.52_ref4 publication-title: Arthritis Rheum doi: 10.1002/art.21749 – volume: 36 start-page: 259 year: 2007 ident: 10.3343/alm.2013.33.1.52_ref16 publication-title: Scand J Rheumatol doi: 10.1080/03009740701286813 – volume: 8 start-page: 345 year: 2007 ident: 10.3343/alm.2013.33.1.52_ref8 publication-title: Nat Immunol doi: 10.1038/ni0407-345 – volume: 373 start-page: 659 year: 2009 ident: 10.3343/alm.2013.33.1.52_ref1 publication-title: Lancet doi: 10.1016/S0140-6736(09)60008-8 – volume: 31 start-page: 606 year: 2011 ident: 10.3343/alm.2013.33.1.52_ref9 publication-title: J Clin Immunol doi: 10.1007/s10875-011-9540-8 – volume: 138 start-page: 107 year: 2011 ident: 10.3343/alm.2013.33.1.52_ref11 publication-title: Clin Immunol doi: 10.1016/j.clim.2010.10.002 – volume: 10 start-page: R93 year: 2008 ident: 10.3343/alm.2013.33.1.52_ref18 publication-title: Arthritis Res Ther doi: 10.1186/ar2477 – volume: 179 start-page: 1449 year: 2007 ident: 10.3343/alm.2013.33.1.52_ref14 publication-title: J Immunol doi: 10.4049/jimmunol.179.3.1449 – volume: 39 start-page: 18 year: 2012 ident: 10.3343/alm.2013.33.1.52_ref21 publication-title: J Rheumatol doi: 10.3899/jrheum.110697 – volume: 41 start-page: 87 year: 2008 ident: 10.3343/alm.2013.33.1.52_ref22 publication-title: Immunol Res doi: 10.1007/s12026-007-8014-9 – volume: 44 start-page: 2413 year: 2001 ident: 10.3343/alm.2013.33.1.52_ref3 publication-title: Arthritis Rheum doi: 10.1002/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E – volume: 103 start-page: 1345 year: 1999 ident: 10.3343/alm.2013.33.1.52_ref7 publication-title: J Clin Invest doi: 10.1172/JCI5703 – volume: 71 start-page: 134 year: 2010 ident: 10.3343/alm.2013.33.1.52_ref26 publication-title: Scand J Immunol doi: 10.1111/j.1365-3083.2009.02361.x – volume: 67 start-page: 1299 year: 2008 ident: 10.3343/alm.2013.33.1.52_ref10 publication-title: Ann Rheum Dis doi: 10.1136/ard.2007.080341 – volume: 60 start-page: 1647 year: 2009 ident: 10.3343/alm.2013.33.1.52_ref19 publication-title: Arthritis Rheum doi: 10.1002/art.24568 – volume: 7 start-page: 429 year: 2007 ident: 10.3343/alm.2013.33.1.52_ref2 publication-title: Nat Rev Immunol doi: 10.1038/nri2094 – volume: 62 start-page: 2876 year: 2010 ident: 10.3343/alm.2013.33.1.52_ref23 publication-title: Arthritis Rheum doi: 10.1002/art.27622 – volume: 38 start-page: 44 year: 1995 ident: 10.3343/alm.2013.33.1.52_ref17 publication-title: Arthritis Rheum doi: 10.1002/art.1780380107 – volume: 62 start-page: 383 year: 2010 ident: 10.3343/alm.2013.33.1.52_ref24 publication-title: Arthritis Rheum doi: 10.1002/art.27186 – volume: 26 start-page: 75 year: 1993 ident: 10.3343/alm.2013.33.1.52_ref25 publication-title: Clin Biochem doi: 10.1016/0009-9120(93)90032-2 – volume: 183 start-page: 2593 year: 1996 ident: 10.3343/alm.2013.33.1.52_ref5 publication-title: J Exp Med doi: 10.1084/jem.183.6.2593 – volume: 30 start-page: 301 year: 2010 ident: 10.3343/alm.2013.33.1.52_ref20 publication-title: Korean J Lab Med doi: 10.3343/kjlm.2010.30.3.301 – volume: 37 start-page: 2014 year: 2010 ident: 10.3343/alm.2013.33.1.52_ref12 publication-title: J Rheumatol doi: 10.3899/jrheum.100259 – volume: 8 start-page: 967 year: 2007 ident: 10.3343/alm.2013.33.1.52_ref13 publication-title: Nat Immunol doi: 10.1038/ni1488 – volume: 160 start-page: 3513 year: 1998 ident: 10.3343/alm.2013.33.1.52_ref6 publication-title: J Immunol doi: 10.4049/jimmunol.160.7.3513 – reference: 7818570 - Arthritis Rheum. 1995 Jan;38(1):44-8 – reference: 20682664 - J Rheumatol. 2010 Oct;37(10):2014-20 – reference: 8485860 - Clin Biochem. 1993 Apr;26(2):75-84 – reference: 17763202 - Scand J Rheumatol. 2007 Jul-Aug;36(4):259-64 – reference: 20583102 - Arthritis Rheum. 2010 Oct;62(10):2876-85 – reference: 8676080 - J Exp Med. 1996 Jun 1;183(6):2593-603 – reference: 20415779 - Scand J Immunol. 2010 Mar;71(3):134-45 – reference: 18172584 - Immunol Res. 2008;41(2):87-102 – reference: 21056009 - Clin Immunol. 2011 Jan;138(1):107-16 – reference: 19479869 - Arthritis Rheum. 2009 Jun;60(6):1647-56 – reference: 18710567 - Arthritis Res Ther. 2008;10(4):R93 – reference: 11665984 - Arthritis Rheum. 2001 Oct;44(10):2413-24 – reference: 21801431 - Arthritis Res Ther. 2011;13(4):R126 – reference: 17581537 - Nat Immunol. 2007 Sep;8(9):967-74 – reference: 10225978 - J Clin Invest. 1999 May;103(9):1345-52 – reference: 17641010 - J Immunol. 2007 Aug 1;179(3):1449-57 – reference: 18063670 - Ann Rheum Dis. 2008 Sep;67(9):1299-304 – reference: 9531313 - J Immunol. 1998 Apr 1;160(7):3513-21 – reference: 16572447 - Arthritis Rheum. 2006 Apr;54(4):1122-31 – reference: 17525752 - Nat Rev Immunol. 2007 Jun;7(6):429-42 – reference: 21556937 - J Clin Immunol. 2011 Aug;31(4):606-14 – reference: 17375096 - Nat Immunol. 2007 Apr;8(4):345-50 – reference: 22133625 - J Rheumatol. 2012 Jan;39(1):18-21 – reference: 20603592 - Korean J Lab Med. 2010 Jun;30(3):301-6 – reference: 20112361 - Arthritis Rheum. 2010 Feb;62(2):383-91 – reference: 19157532 - Lancet. 2009 Feb 21;373(9664):659-72 |
SSID | ssj0000601290 |
Score | 2.175689 |
Snippet | Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We... Background: Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 52 |
SubjectTerms | Adult Aged Arthritis, Rheumatoid - blood Arthritis, Rheumatoid - metabolism Arthritis, Rheumatoid - pathology Blood Sedimentation C-Reactive Protein - analysis Cytokines - blood Female Humans Male Middle Aged Original Osteoarthritis - blood Osteoarthritis - metabolism Osteoarthritis - pathology Severity of Illness Index Th1 Cells - cytology Th1 Cells - immunology Th1 Cells - metabolism Th17 Cells - cytology Th17 Cells - immunology Th17 Cells - metabolism 병리학 |
Title | Elevated Levels of T Helper 17 Cells Are Associated with Disease Activity in Patients with Rheumatoid Arthritis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23301223 https://www.proquest.com/docview/1273346425 https://pubmed.ncbi.nlm.nih.gov/PMC3535197 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001730163 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Annals of Laboratory Medicine, 2013, 33(1), , pp.52-59 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbYkBAviN-UwWQkXnhIN8d24jwgVI2NgShCaJX6Zl1ie60WJSNtJ_jvuWuSQlHFA0-R40ss-Wzf9_nsO8Ze40DxBqsiyEIaKYremnudR1IbcCKkCLLpcvL4S3I-UZ-mevr7enTXgYud1I7ySU2acvjj-893OOHfEuOUSh5BSVfKhcTSUAw1Lsi30S4lRMXGHdhv1-V-0wVNooqkOe78ljt_QlGCkeuLOJZbJmuvasIuNPr3oco_rNTZfXavg5d81I6HB-yWrx6yO-POgf6I1aelv0F46fhnOi204HXgFxxtz7VvuEj5iS_x5ajxvNcbitJeLX_fenL4qGjzTfB5xb-2QVkXrcS3mV8h_q3njtqfraMlPWaTs9OLk_Ooy7kQFUqLZWRAgfdZlkrQicviNAuQOuOdyRUIpUFKgNwQJs99cAg3IVHOI80qkgQQvjxh-1Vd-WeMK-lSWZhQgA4q8wBBZHCcFUKHAALMgB313WqLLiA55cUoLRIT0olFnVjSCZassDoesDebL67bYBz_kH2FmrJXxdxSBG16Xtb2qrHIEz4i4YkRiKFMr0eLs4pcJVD5erWwAlGdVMjN9IA9bfW6abEfFgOWbml8I0DtbddU89k6crfUlA8xff7fXx6wu_E6HwftAb1g-8tm5V8iKlrmh2zvw1Qcrof8L41YC9c |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+Levels+of+T+Helper+17+Cells+Are+Associated+with+Disease+Activity+in+Patients+with+Rheumatoid+Arthritis&rft.jtitle=Annals+of+laboratory+medicine&rft.au=Kim%2C+Jimyung&rft.au=Kang%2C+Seongwook&rft.au=Kim%2C+Jinhyun&rft.au=Kwon%2C+Gyechul&rft.date=2013-01-01&rft.pub=The+Korean+Society+for+Laboratory+Medicine&rft.issn=2234-3806&rft.eissn=2234-3814&rft.volume=33&rft.issue=1&rft.spage=52&rft.epage=59&rft_id=info:doi/10.3343%2Falm.2013.33.1.52&rft_id=info%3Apmid%2F23301223&rft.externalDocID=PMC3535197 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-3806&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-3806&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-3806&client=summon |